FSCN1 and carcinoma of esophagus: A systematic review and meta-analysis consisted of almost 9000 patients (26 studies using immunohistochemistry) with breast, colorectal, gastric, lung and oesophageal cancer demonstrated that high fascin expression is associated with increased mortality and disease progression [29].